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Breast cancer is a malignant epithelial neoplasm with high incidence and mortality in women. Focusing 
the clinical performance on screening processes has proven to be the way to improve morbidity and 
mortality statistics of this recognized public health problem. Business process management (BPM) is a 
management field that improves and analyzes business processes according to organizations’ 
strategies. BPM may help manage patient and information flow, improving waiting time in healthcare 
delivery while integrating healthcare processes with IT. The early diagnosis of breast cancer is of great 
importance since it will enable more conservative treatments and a longer disease-free survival. 
Organized oncology screenings programs, with all elements properly prepared, revealed to be more 
efficient than the opportunistic screenings. The aim of this study is to identify and model BPM 
processes for the healthcare sector, namely, for the breast cancer screening in Portugal. To achieve 
this goal, the main processes were identified and new frameworks were proposed and validated 
through individual interviews with experts. In this study was concluded that BPM techniques can be 
applied to the healthcare. Through the application of these techniques it was possible to identify the 
main issues within the organized breast cancer screening and suggest changes to it. These changes 
focus on reducing the time of the process, improving its efficiency and offering greater support to the 
health user.  
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Breast cancer is a public health problem since it’s the most frequent cancer among women and one of 
the principal causes of cancer related death in women worldwide (IARC, 2016; Mathioudakis et al., 
2019; Obaidullah, Ahmed, Gonçalves, & Rato, 2019). According to the International Agency for 
Research on Cancer (IARC), 2016, “before age of 75 years, 1 in 22 women will be diagnosed with breast 
cancer and 1 in 73 women will die from breast cancer, worldwide”. In Portugal, in 2012, more than 
6000 new cases appear and around 1600 women, per year, died with this disease (Lacerda et al., 2019). 
Breast cancer is a malignant epithelial neoplasm, characterized by an uncontrolled growth of the 
abnormal breast cells with metastasis capacity (Cardoso, 2017). It is classified in different subtypes 
according to histological type, differentiation and the tumor-node-metastasis staging system (Cardoso, 
2017). The early diagnosis of breast cancer is of great importance since the detection of small tumors, 
which are only detectable in ultrasound and mammography, or tumors in evolutionary phase non-
invasive, will enable treatments less mutilating, with more conservative surgeries and a longer disease-
free survival (Cardoso, 2017). Oncology screening allow earlier diagnosis of the disease, in subclinical 
stages, and aims the reduction of cancers’ mortality (Miranda, 2016). Any screening program is 
dependent of a sequence of interventions, beginning in the identification of the target population until 
the post treatment (Miranda, 2016). 
Business process management (BPM) is a management field characterized for being a well-designed, 
implemented, executed, integrated, monitored and controlled approach, that improves and analyzes 
business processes according to organizations’ strategies (Buttigieg, Dey, & Gauci, 2016; Lopez-
Sanchez, Campos, & Musavi, 2009).  A business process is composed by structured and interconnected 
activities, which produce a service or product focused in the client’s needs (Lopez-Sanchez et al., 2009). 
BPM has six core elements that are needed for a proper implementation, namely: Strategic alignment, 
Governance, Methods, Information technology (IT), People and Culture (Buttigieg et al., 2016).  
Targeting optimal patient outcomes is the aim of health service delivery. Additionally, focusing the 
clinical performance on processes has been proving to be the way to improve morbidity and mortality 
disease statistics (Buttigieg et al., 2016).  
BPM in healthcare may support the development of standardized processes, minimizing the variation 
in quality of healthcare delivery and errors, and selecting the right enablers in information 
management and technology to manage these processes (Buttigieg et al., 2016).  Furthermore, BPM 
can also help manage patient and information flows, improving waiting time in healthcare delivery 
while integrating healthcare processes with IT (Buttigieg et al., 2016).  
The application of BPM techniques has been increasing in public health, although there are still some 
failures due to improper adoption of BPM and because of content and structural issues present in the 
health care sector (Buttigieg et al., 2016). Due to the highly complex and multidisciplinary processes 
existing in healthcare systems, the application of BPM becomes a challenge (Buttigieg et al., 2016). 
BPM principles may be applied in hospitals but also in other settings like primary care and 
rehabilitation units (Buttigieg et al., 2016).  
In order to properly implement BPM in organized breast cancer screening programs, two research 
questions should be answered: (1) What are the processes involved in the breast cancer screening in 
Portugal? (2) What are the constraints of the breast cancer screening programs?  
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The current widespread of technology and its importance in several different areas, including diagnosis 
and treatment of oncology diseases, makes it an important feature to improve the quality and the 
implementation of preventive and screening actions. Technology and healthcare professionals must 
be connected, allowing the development of multidisciplinary teams responsible for the patients 
tracking since the detection and preventive stage. Organized screening programs, with all elements 
properly prepared, revealed to be more efficient than the opportunistic screenings (non-organized and 
unmonitored) (Miranda, 2016). BPM gets its role on optimizing and managing all processes from the 
screening until the diagnosis and treatment.  
The goal of this dissertation is the optimization, identification and modelling of BPM processes for the 
Portuguese breast cancer screening, by: 
• Identification of the “AS-IS” model for the processes of the screening of breast cancer, 
according to a major player (Portuguese League Against Cancer); 
• Description of each activity present in the process and the role of each stakeholder; 
• Identification of bottlenecks and problems; 
• Process improvements proposal considering the available information and “AS-IS” 
model analysis. 
• Development and validation of the “TO-BE” models.  
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2. LITERATURE REVIEW 
2.1. BREAST CANCER 
The human body is composed of several millions of cells which coordinate between themselves to 
constitute tissues and organs (Devarriya, Gulati, Mansharamani, Sakalle, & Bhardwaj, 2019). Normal 
cells grow and divide for a period of time and then stop growing and dividing until its needed again to 
replace defective or dying cells (Bhardwaj & Tiwari, 2015; Devarriya et al., 2019). When this cell’ 
reproduction become out of control and the cells lose their ability to stop dividing and spreading, a 
mass called tumor is formed and the cancer appears (Bhardwaj & Tiwari, 2015; Devarriya et al., 2019; 
Mušić & Gabeljić, 2019). The tumor can be classified as benign or malign according to its features 
(Bhardwaj & Tiwari, 2015; Devarriya et al., 2019; Mušić & Gabeljić, 2019). 
Breast cancer is a malignant cell growth in the breast tissue which has the capacity to spread to other 
areas of the body when left untreated (Bhardwaj & Tiwari, 2015; Devarriya et al., 2019). It is classified 
according to stages which describe the size of the tumor and if it has spread to lymph nodes or 
metastasized to distant organs. The staging system normally used for breast cancer is the tumor-node-
metastasis (TNM) classification. In the TNM classification, stage I and II are for localized disease, stage 
III is for regional disease and stage IV is for distant disease. Accurate staging provides key prognostic 
information (IARC, 2016). 
The estimated global incidence of breast cancer in 2012, was of 1.68 million new diagnosis of breast 
cancer (43.3 per 100 000) and the estimated mortality was of 0.52 million deaths (12.9 per 100 000), 
as seen in Figure 2.1 (IARC, 2016). Its incidence was three times that the cancer of colorectal (0.61 
million new cases, 14.3 per 100 000), lung (0.58 million new cases, 13.6 per 100 000) and cervix (0.53 
million new cases, 14.0 per 100 000), the next most frequent types of cancer in women (Figure 2.2). 
While its mortality was similar to that from lung cancer (0.49 million deaths, 11.1 per 100 000) and 
significantly greater than that from the colorectal (0.32 million deaths, 6.9 per 100 000) and cervix 
(0.27 million deaths, 6.8 per 100 000) (Figure 2.2) (IARC, 2016).    
 
Figure 2.1 – Estimated global number of new cases and deaths for breast cancer in women, 2012. 




Figure 2.2 – Cancer incidence and mortality rates (estimated age-standardized) worldwide, per 
100 000 in men and women in 2012. Retrieved from (IARC, 2016) 
The risk of a woman develops breast cancer increase with the age, the majority of the cases appear in 
women older than 50 years, and the way to reduce its mortality is with an early detection and effective 
treatment (Bhardwaj & Tiwari, 2015; IARC, 2016). Breast cancer is one of the most treatable types of 




Prevention of cancer can be reached through primary prevention, intended to prevent the occurrence 
of cancer, or through secondary prevention, which has the purpose of an earlier diagnosis of the cancer 
in order to reduce related mortality and distress (IARC, 2016). The principal elements of secondary 
prevention are screening and early clinical diagnosis and they are essential components of any cancer 
control program (IARC, 2016).  
Screening programs promote the detection of cancer at earlier stages, enabling the prescription of 
timely and suitable treatment, making the cure and the reduction of mortality associated with the 
disease realistic possibilities (IARC, 2016). The implementation of these programs aims to impact on 
disease mortality rates, however, the effective outcomes highly depend on the participation of the 
population, which relies on a set of factors such as people’s knowledge and beliefs and on 
organizational aspects of the screening procedures and its availability (Deandrea et al., 2016). Thus, 
the acceptance and use of screening services differ between populations, making a given screening 
organized program not universally cost-effective (IARC, 2016).  
The screening programs can be classified as organized or population-based, and opportunistic. 
Organized screening programs are settled at national or regional level, have a team responsible for 
organization and provision of healthcare, a structure for quality assurance and an explicit policy while 
the opportunistic screenings result from a recommendation from a routine medical consultation, for 
an unrelated problem, based on a possibly increased risk of developing breast cancer (due to family 
history or other risk factors) (IARC, 2016). Population-based screenings reach women who haven’t 
participated in opportunistic screening. These programs enable more equity in access, creating 
conditions for women to obtain adequate diagnosis and treatment, including low users of healthcare 
services and the ones from lower socioeconomic groups (IARC, 2016; WHO, 2014). With universal 
access to rapid and effective diagnosis and treatment, the potential impact of early detection of cancer 
boosts (Anttila et al., 2015).  
Opportunistic screening is less susceptible to quality assurance compared to the organized programs 
considering its lack of administrative and organization infrastructure (IARC, 2016).  As mentioned by 
IARC, 2016, the organized programs include “centralized screening invitations to a well-defined target 
population, systematic call and recall for screening, delivery of test results, investigations, treatment 
and follow-up care and a program database with linkages to other information systems” and an 
administrative structure responsible for service delivery like follow-up of lesions, quality assurance and 
evaluation (IARC, 2016). 
Table 2.1 presents both the advantages and disadvantages of opportunistic and population-based 
screening. 




All women (both the ones that 
are invited to organized 
screenings and the ones that 
are not included) can 
participate; 
 
Dependent on the initiative of 
individual healthcare providers 
to offer screening; 
 




Enable the access to screenings 
in areas where organized 
screenings don’t exist. 











Attract women of lower 
socioeconomic status who 
would not usually undergo 
mammography screening; 
 
Equitable access to screening; 
 
Uses resources more efficiently; 
 




screening, biennially, is cost-
effective; 
 
Can shorten the interval 
between diagnosis and start of 
treatment through prompt 
referral to hospital units. 
Overdiagnosis (detection of 
breast cancer by screening that 
otherwise would never have 
presented clinically during the 
woman’s lifetime) and 
consequently overtreatment; 
 
Resource costs in finding more 
illness and the subsequent 
management of what is 
discovered; 
 
Anxiety felt by all individuals 
tested between undergoing the 
screening test and the final 
diagnosis. 
Table 2.1 – Comparison between Breast Cancer Opportunistic and Organized Screenings. (Anttila et 
al., 2015; Holland, 2006; IARC, 2016; WHO, 2014) 
2.2.1. Breast Cancer Organized Screening 
Since the late 1980s, good evidence emerging from trials on the effectiveness of breast cancer 
screening has become available, so screening programs have been in place in Europe (Deandrea et al., 
2016). In the subsequent years was described a gradual implementation of breast cancer screening 
programs, however, with some heterogeneity and different policies (Deandrea et al., 2016).  With this, 
the council recommendation of December 2nd, 2003, at European Union level, stablished a list of 
requirements to implement organized, population-based breast cancer screening programs (Deandrea 
et al., 2016). 
Currently, the breast cancer screening with mammography alone is the population-based method used 
in the majority of the European countries for the early detection of this cancer (Mathioudakis et al., 
2019). Screening asymptomatic women includes the execution of mammography screening, at 
specified intervals, and referring those women with positive results for additional diagnostic 
investigations and possibly treatment (IARC, 2016). A decrease on the breast cancer mortality in 
women aged 50 to 74 years has been shown (Mathioudakis et al., 2019). Within all of the European 
7 
 
countries, only France added a clinical breast examination to the mammography (Deandrea et al., 
2016). The screening programs are offered to normal-risk women beginning with ages comprised 
between 40 to 50 years old and ending with ages between 69 to 74 years old and usually in intervals 
of two years (IARC, 2016).  
Mammography can be used to check for breast cancer in women without signs or symptoms of the 
disease and is characterized for being an imaging modality specifically for breast tissue, which uses low 
energy X-ray (Mušić & Gabeljić, 2019). From all the breast cancers detected by mammography 
screening, less than one third would also be detectable by clinical examination (IARC, 2016). Normally, 
in the screening programs, the mammography involves two views (X-ray images) of each breast and 
double reading (Mušić & Gabeljić, 2019). With this technique it is possible the early detection of 
malignant tumors before the tumor spreads (Mušić & Gabeljić, 2019).  
However, mammography screening has also some limitations and undesirable effects associated. As 
for example, it is not effective in detecting lesions in women with radiologically dense breasts, the 
radiation exposure and the false-negative or false-positive mammography results (Mathioudakis et al., 
2019; Mušić & Gabeljić, 2019; Sadeghi et al., 2019).  The reported rate of false-negative results in 
mammography is of at least 10% and false-positive results can lead to anxiety and psychological 
distress (Mušić & Gabeljić, 2019). There isn’t yet a completely consensus on the harm-benefit balance 
of breast cancer screening thus, women need to receive balanced and adequate information to make 
informed decisions related to their participation in screening programs (Mathioudakis et al., 2019). It’s 
essential an efficient communication in order to help women make an informed decision concerning 
their participation in the screening (IARC, 2016). 
Although clinical breast examination and breast self-examination don’t make part of the screening 
program, they can complement it. The first technique involves systematic palpation of both breasts 
and nipples and visual inspection by a trained health-care provider. While the second, is an 
examination done by the women herself of her breasts (IARC, 2016). These techniques are only useful 
for detecting suspicious breast lesions, once it doesn’t determine malignancy with assurance (Jaglan, 
Dass, & Duhan, 2019). 
2.2.2. Challenges for Breast Cancer Organized Screening 
Although mammography continues to be the gold standard of the screening methods (Sadeghi et al., 
2019), it has some limitations as previously mentioned. As so, it’s essential to find a way to solve these 
limitations. Nowadays, research and discussions moved on to the use of digital breast tomosynthesis 
as routine for screening programs. But, until now no single screening program has changed to routine 
use of digital breast tomosynthesis (IARC, 2016).  
Digital breast tomosynthesis derives from digital mammography and produces quasi three-
dimensional images, reducing the effect of tissue superimposition, which allows better visualization 
and localization of potential lesions, improving mammography interpretation (IARC, 2016). It improves 
the rate of cancer detection and reduce the proportion of patients’ recall for additional imaging studies 
(Ikejimba et al., 2019). Although the radiation dose of digital mammography with tomosynthesis is 
around twice of the dose of mammography alone, it is considerably reduced by reconstruction of two-
dimensional images from the three-dimensional images (IARC, 2016). 
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Other imaging techniques available are: breast ultrasonography, magnetic resonance imaging (MRI), 
electrical impedance technology for breast imaging, scintimammography, and positron emission 
mammography. In non-randomized studies, for ultrasonography and digital breast tomosynthesis, 
there were evidence of incremental cancer detection when used as complement screening to 
mammography (IARC, 2016). Other studies have shown that breast ultrasonography and breast MRI 
are the best alternatives for mammography and may improve the breast cancer prognosis (Jaglan et 
al., 2019).  
Breast ultrasonography screening have frequently focused on populations with mammographic 
density since dense breast tissue is a risk factor for breast cancer and reduces the sensitivity of 
mammography, consequently it is associated with greater probability of an interval cancer in 
mammography screening. Ultrasonography-only detected cancers were usually early-stage cancers, 
comparable or even in earlier stages than cancers detected through mammography (IARC, 2016). 
Breast MRI have been proving to be a good alternative to mammography since it doesn’t involve 
radiation exposure however, its specificity is too low and the interpretation is complex and not 
standardized, being recommended only for screening of high-risk women (Jaglan et al., 2019).  
Molecular diagnostics are revolutionizing human oncology in order to enable early detection, target 
therapies or monitoring treatment (Wiley, Wise, & Breen, 2019). Liquid biopsies, through the 
identification of genetic signatures associated with cancers, allow the detection of tumors in preclinical 
stages (Gerratana et al., 2019; Wiley et al., 2019). This is a recent technique but efforts are being done 
to use them in early stage breast cancer, with respect to early disease detection and minimal residual 
disease, offering new opportunities for improving cancer screening (Gerratana et al., 2019; Wiley et 
al., 2019).  
In order to early and accurately identify the breast cancer it’s important to ensure the extraction of 
information from previous diagnosis data (Bhardwaj & Tiwari, 2015; Devarriya et al., 2019). Since 
machine learning techniques enable computers to learn from past data and patterns its usage in 
medical diagnosis is gradually increasing (Bhardwaj & Tiwari, 2015). Computer-aided diagnosis systems 
are being proposed since it helps reducing the number of unnecessary breast biopsies (Mušić & 
Gabeljić, 2019). As concluded by Mušić et Gabeljić, 2019, the use of neural network to classify 
mammographic tumors is benefic and should be used by physicians to improve quality, accuracy and 
potentially the speed of digital mammography. 
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2.3. PORTUGUESE LEAGUE AGAINST CANCER 
The Portuguese league Against Cancer (LPCC) was founded in April 4th, 1941, proposed by Francisco 
Gentil. The league is based in two principles: the humanization and the solidarity (LPCC, 2019). It is a 
national entity of reference in the support for oncology patients and their family, in promoting health, 
in cancer prevention and in promoting research and training in oncology. It is composed by five 
regional nuclei: Azores, Centre, Madeira, North and South (LPCC, 2019).  
The increasing focus of resources on patient’ care and on the early detection of the disease led to the 
creation of one of the most important initiatives of the league: National Breast Cancer Screening 
Program. Currently, the LPCC is responsible for the majority of the breast cancer population-based 
screenings in Portugal. The population program covers completely the region of the center (78 
municipalities), the districts of Beja, Braga, Bragança, Évora, Portalegre, Santarém, Viana do Castelo 
and Vila Real, the majority of the municipalities of the district of Porto, the municipality of Azambuja 
(Lisbon) and the municipalities of Alcácer do Sal, Sines, Grândola and Santiago do Cacém (Setúbal) 
(LPCC, 2019). 
In this research project the breast cancer screening process followed by the LPCC nuclei of the south 
will be used as the case study (Figure 2.3).  
 
Figure 2.3 – Regions covered by the nuclei of the south of the Portuguese League Against Cancer. 
Provided by the LPCC 
Two mobile units are used to perform the screening and every two years go to municipalities and fixed 
units. Inviting letters are sent to women with ages between 50 to 69 years old that are enrolled in the 
Health Units, in order to perform a mammogram (free exam). This exam is evaluated by two 
radiologists that in case of doubt call the woman to a clinic consultation and if this doubt persist she’s 
referred to hospital facilities where a final diagnostic will be done. If suspicions are confirmed the 
woman goes to treatment (LPCC, 2019). 
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2.4. BUSINESS PROCESS MANAGEMENT 
Business Process Management (BPM) has gain power and interest to organizations due to its capacity 
to help achieve operational excellence, increase productivity and save costs (Recker & Mendling, 
2016). It is considered to be a management discipline which associates knowledge from information 
technology with management sciences and applies that to business processes (ABPMP, 2013; van der 
Aalst, 2013).  
BPM is a term used since 2002, which represents a body of knowledge comprised by principles and 
best practices to guide an organization through focused management of the organization’s business 
processes, in order to continuously improve and achieve their objectives more efficiently (ABPMP, 
2013; Combi, Oliboni, & Zerbato, 2019; Froger, Bénaben, Truptil, & Boissel-Dallier, 2019). Its basis is 
an explicit representation of the activities and execution constraints between them, involved in the 
business processes (Hajiheydari & Dabaghkashani, 2011).  
A business process is defined as a complete and dynamically coordinated set of activities, related 
across time and space, that transform one or more inputs into a specific output with value to a 
customer, either a product or a service (ABPMP, 2013; Combi et al., 2019; Hajiheydari & 
Dabaghkashani, 2011). The way processes are designed and executed affect the quality of the service 
perceived by the customer as well as the efficiency with which services are delivered (Dumas, La Rosa, 
Mendling, & Reijers, 2018).   BPM includes methods and tools to support tasks of modelling, managing 
and analyzing of these processes, helping optimize the means by which the organization delivers their 
output (ABPMP, 2013; Dani, Freitas, & Thom, 2019). The design, administration, configuration and 
enactment of business processes are also integrated as capabilities of BPM techniques (Hajiheydari & 
Dabaghkashani, 2011). Since business processes are becoming more complex, process modelling has 
becoming of greatest importance for organizations (van der Aalst, 2013). 
As referred by Van der Aalst, 2013, BPM aims achieve operational business processes improvement 
without the use of new technology but it is also frequently associated with software to manage, control 
and support operational processes. BPM can be used in any organization, from for-profit to non-profit 
and government entities (ABPMP, 2013). 
According to the ABPMP (2013), when an organization has mature BPM capabilities their processes 
are managed following a closed-loop cycle, which composes the Business Process Lifecycle (ABPMP, 
2013). The number of phases present in this lifecycle and the labels used to describe them vary 
between authors, considering this, in this document the DMEMO cycle will be followed (Figure 2.4). 
The DMEMO cycle results from a sequence of five stages: Define, Model, Execute, Monitor and 




Figure 2.4 – The DMEMO process lifecycle. Adapted from (Szelągowski, 2018) 
When starting a BPM initiative, the first question that needs to be clarified should be: “Which business 
processes do we aim to improve?” (Dumas et al., 2018). Before applying BPM, the team should have 
an idea of what business processes may be causing problems (Dumas et al., 2018). Considering this, 
it’s important to start the BPM practices by describing the processes of the organization, building “AS-
IS” models, and analyzing them according to the organization’s data and the knowledge of its 
employees, which corresponds to the definition stage (Szelągowski, 2018). A critical step in BPM is 
understand the value delivered by a process, by measuring it. To do that it’s important to determine 
the process performance measures that will be used to evaluate if a process is valuable or not (Dumas 
et al., 2018).  
With the result of the previous analysis, composed by an understanding  of the issues in the process 
and the potential solutions, an improved process model is prepared (the “TO-BE” model) which 
corresponds to the Model stage (Dumas et al., 2018; Szelągowski, 2018). The next phase is the 
Execution, where personnel’s training and changes to their work is done, as well as changes to the IT 
systems, including process performance automation. The goal of the Monitor phase is to perform and 
monitor business operations in agreement with organized and implemented process descriptions. 
When expectations are no longer accomplished, adjustments to the implemented business process 
are required which corresponds to the last stage, the Optimization (Dumas et al., 2018). At this phase, 
the process performance is evaluated and the process descriptions are improved with the purpose of 
raising efficiency and minimizing risks (Szelągowski, 2018).  
2.4.1. AS-IS Model and TO-BE Model 
In order to properly analyze and change a specific business process, it’s necessary to start by 
understanding its current state, creating one or several “AS-IS” models (ABPMP, 2013). This process 
model should reproduce what people in the organization understands about how work is done (Dumas 
et al., 2018). To capture all the needed information, many different methods can be used, as for 
example: direct observation, one-on-one interviews, written feedback, structured workshops and web 
conferencing. While using these techniques, some inconsistencies, unnecessary activities and 
opportunities for improvement can be noticed (ABPMP, 2013). So, with these problems identified, a 
redesigned version of the process can be proposed, the “TO-BE” model, which is the main output of 
the process improvement (model phase) (Dumas et al., 2018). In this stage, analysis and redesign are 
12 
 
associated because several redesign options can be considered and each one of them needs to be 
analyzed in order to choose the preferable one (Dumas et al., 2018).  
2.4.2. Process Performance Measures 
Process performance management should begin with the examination of the processes that will be 
monitored for performance. When properly identified, it’s important to understand processes 
effectiveness, if they deliver what is supposed to or not (ABPMP, 2013).  
A process performance measure is defined by Dumas, 2018, as a quantity that can be clearly 
determined for a given business process. According to ABPMP (2013) and Dumas (2018) there are four 
fundamental measurements:  
• Time – Associated with process duration. The cycle time measures the time taken from 
the start of a process until its completion, considering the output; 
• Cost – Value associated with a process, which is typically a monetary value. There are 
different perspectives on cost, being possible to distinguish between fixed (almost not 
affected by the intensity of processing) and variable (positively correlated with some 
variable quantity) or it can be related to productivity, operational cost (directly related 
to the outputs of the business process); 
• Capacity – Amount or volume of a realistic output related to a process; 
• Quality – Normally expressed as a percentage of actual to optimal or maximum. It can 
be seen from two different angles: external quality (client’s satisfaction with the product 
or the process) and internal quality (process participants’ viewpoint).  
Quality is the hardest measure to define in terms of oncology screenings, being evaluated on the basis 
of a set of performance indicators, like detection rates and the predictive values of the tests (Ponti et 
al., 2017).  A screening program in order to be considered to have quality should be safe, efficient, 
effective and offer equity in access (National Screening Unit & Ministry of Health, 2005).  
Finally, when redesigning a business process, the time required to handle a case and the cost required 
for executing the process should decrease, the quality of the service delivered should be improved, 
and the resilience of the business process to deal with variation should increase (Dumas et al., 2018). 
2.4.3. Transformation Techniques  
Besides BPM, many other disciplines deal with business processes, being focused in improving the 
operational performance of the organization (Dumas et al., 2018). Several management disciplines can 
be used to define improvement opportunities like: 
• Lean - is an approach that has as one of the main principles the elimination of the waste 
or non-value-add work while focusing on continuous improvement to optimize the 
operations, providing higher quality, reduced cycle time and lower costs (ABPMP, 2013; 
Dumas et al., 2018). It focuses on the people of the organization through the creation 
of a culture that empowers staff at all levels to make innovative changes to improve 
productivity whilst reducing waste (Pearce & Pons, 2013). Nowadays, Lean is supported 
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by tools and statistical methods that are important for improvement projects. Normal 
results show reductions in time aligned with quality increase and the cost of quality 
decreases (ABPMP, 2013; Pearce & Pons, 2013). The application of lean is based on five 
steps (Amador, 2013): (1) define value from a customer’s perspective; (2) identify value 
stream; (3) make the value flow without interruptions by eliminating when possible 
waste between steps of the process; (4) implement customer “pulls” service and (5) 
pursue perfection continuously. 
• Six Sigma - is a method that improves business performance by reducing variation in 
work or in quality and by minimizing defects (errors) (ABPMP, 2013; Dumas et al., 2018). 
It has become one of the most accepted enterprise improvement methodologies for 
organizations chasing to identify business problems and define improvement 
opportunities (ABPMP, 2013). In practice, Six Sigma is not necessarily applied alone but 
combined with other methods as for example with Lean, being referred as Lean/Six 
Sigma (ABPMP, 2013; Dumas et al., 2018).  
2.4.4. Process Modelling Notation - BPMN 2.0  
A notation is defined as a standardized set of symbols and rules that manage how something is 
represented. In business process modelling notation icons and connectors are included to assist in the 
representation of relationships between components of a business process. There are available several 
modelling and notational standards and techniques (ABPMP, 2013). This research study applies 
Business Process Model and Notation (BPMN) 2.0, which is considered the main standard and was 
created by the Business Process Management Initiative, now merged with the Object Management 
Group (OMG) (ABPMP, 2013; Sang & Zhou, 2015). BPMN is a technique, frequently used as notation in 
the process modelling tasks, that uses structured analysis to diagrammatically represent business 
processes and aims providing, to all business users, an easy-to-understand notation (Dani et al., 2019; 
Georgiou et al., 2019).  
BPMN 2.0 is an extremely accurate notation that indicates the beginning, intermediate and end events; 
activities and message flows; intra-business communications and inter-business collaboration, activity 
and data flows (ABPMP, 2013). According to Dani et al. (2019), Combi et al. (2019) and White (2004), 
there are four basic categories of BPMN elements, each other with several core elements:  
1. Flow objects:  
• Events: representation of actions that occur during process execution and affect the 
sequencing or timing of process activities. Normally have a cause (trigger) or an impact 
(result) and are represented as circles with open centers. They can be of three types, 
concerning when they affect the process flow:  
o Start: initiate a process instance;  
o Intermediate: indicate where something happens somewhere between the start 
and end of a process;  





Figure 2.5 – Symbols for start, intermediate and end events (from left to right) 
• Activities: are represented by a rounded-corner rectangle and can be of two types: Task 
and Sub-process. It is called task when it’s seen as single unit of work, it cannot be 
broken into a finer level of abstraction. If a process is too complex, subsets of its 
elements can be grouped to form sub processes within the main process, represented 
by a small plus sign in the bottom center of the shape.  
 
 
Figure 2.6 – Symbols for tasks and sub-processes (from left to right) 
• Gateways: elements in the process, that can also be called as decision points, used to 
control the divergence and convergence of the sequence flow. They are represented by 
a diamond shape and can be of three types: AND, for concurrency (two or more activities 
that can be executed in parallel); OR, for inclusive choices (one or more options can be 
true at the same time) and XOR, for exclusive choice (outcomes are mutually exclusive). 
 
 
Figure 2.7 – Symbols for the different types of Gateways 
2. Connecting Objects: 
• Sequence Flow: is used to link two elements and handle the order through which a 
process will be executed. It is represented by a solid line with a solid arrowhead.  
• Message flow: is used to demonstrate the flow of messages between two participants. 
It is represented by a dashed line with an open arrowhead. 
• Association: is used to associate data, text and other artefacts with flow objects. It is 
represented by a dotted line with a line arrowhead.  
 
 
Figure 2.8 – Symbols for sequence flow, message flow and association (from left to right) 
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3. Swimlanes:  
• Pools: join elements of an organization, represents a participant in a process 
• Lanes: divide a pool into different organization’s resources, being used to organize and 
categorize activities. It’s a sub-partition within a pool. 
 
 
Figure 2.9 – Symbols for pools and lanes 
4. Artefacts:  
• Data objects: present how data is required or created by activities 
• Group: is used for documentation or analysis purposes, but does not affect the sequence 
flow. It is represented by a rounded corner rectangle drawn with a dashed line 
• Annotation: is a mechanism to provide additional text information for the reader of a 
BPMN Diagram   
 
 
Figure 2.10 – Symbols for data objects, groups and annotations (from left to right) 
Amongst others, its advantages are widespread usage and understanding and being one of the most 
powerful and versatile notations for identifying process constraints (ABPMP, 2013). On the other hand, 
some identified disadvantages are: (1) requires training and experience to use full set of symbols 
correctly; (2) challenge to see relationships between multiple levels of a process; (3) doesn’t support 
security aspects as confidentiality (ABPMP, 2013; Sang & Zhou, 2015). 
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2.5. ARTIFICIAL INTELLIGENCE (AI)  
2.5.1. Data Cleaning  
In the healthcare sector as in several other areas, the databases contain raw data that is 
unpreprocessed, incomplete and noisy. In this way, the databases should undergo pre-processing, 
through data cleaning and data transformation (Larose & Larose, 2015).   
Data cleaning also called data cleansing or scrubbing refers to all types of tasks and activities to detect 
and repair errors and inconsistencies in the data. While collecting and acquiring data some errors are 
often introduced, such as missing values, typos, mixed formats and others (Ilyas & Chu, 2019; Rahm & 
Do, 2000). It is composed by repeated cycles of four phases: screening, diagnosis, treatment and 
documentation. Screening is look systematically for suspect features in assessment questionnaires, 
databases or analysis datasets. The diagnosis is responsible for identify the nature of the defective 
data and the treatment involves deleting, editing or leaving the data as it is. These two phases require 
a complete understanding of all sources and types of possible errors during data collection and entry 
processes. The documentation is related to recording modifications enabling the track of errors 
detected, changes, additions and error checking which allows to return to the original value if 
necessary (ACAPS, 2016).  
2.5.2. AI in the Breast Cancer Screening 
It’s been for several decades that intelligent computer systems exist and impact society needs. Several 
different areas are interested in artificial intelligence (AI) research and development, from sectors such 
as technology, communication, to health and industry (Houssami, Kirkpatrick-Jones, Noguchi, & Lee, 
2019).  
In the healthcare sector, AI systems are being developed, explored and evaluated to help in clinical 
decision-making and in the detection and prognostic of diseases, as for example for oncology diseases 
(Houssami et al., 2019). Computer-aided detection (CAD) software was introduced in the 1990s for 
mammography, as an assistance for radiologists with the objective to improve human detection 
performance (McKinney et al., 2020; Rodríguez-Ruiz et al., 2019). However, this generation of software 
failed in improving readers’ performance in real-world settings (McKinney et al., 2020). Unlike them, 
AI is capable of advanced learning and has the potential to do stand-alone interpretations in the future 
(Houssami, Lee, Buist, & Tao, 2017). The substantial improvements in AI, through deep convolutional 
neural networks (usually named as deep learning algorithms), are making closer the performances of 
humans and computers in several medical imaging applications, such as breast cancer detection 
(Rodríguez-Ruiz et al., 2019).  
The screening of breast cancer requires the interpretation of digital mammograms to find suspicious 
abnormalities, which is subjective, and its accuracy varies widely, leaving space for improvement even 
in the performance of the best clinicians (Houssami et al., 2017; McKinney et al., 2020). Although the 
evaluation of patient data and expert judgment are the most important factors in this type of diagnosis, 
there are other factors affecting it, such as the visual perception capacity of the radiologist, less 
experience of the radiologist, the presence of noise in images, poor contrast or inadequate clarity 
(Sadoughi et al., 2018).   
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The usage of AI systems to support breast cancer screening classification could help reducing the 
workload involved in the double-reading process, while maintaining the standard of care (McKinney et 
al., 2020). As mentioned in some studies, AI represents a feasible and timely technology opportunity 
for exploration in breast cancer screening practice (Houssami et al., 2019, 2017).  
Sadoughi et al. (2018) introduce many AI techniques in imaging processing: 
• Support vector machine (SVM) – This technique is inspired by the statistical learning 
theory and has been recently incorporated in the machine learning set. Here, the 
overfitting problem in the training data is reduced and it’s possible the identification of 
a sizeable training set with small subsets of training points.  
• Cascade forward back-propagation network – In this technique each layer of neurons is 
linked to all previous neuron layers and it uses post propagation algorithm to update 
weights, like back- propagation neural network. 
• Feed forward back-propagation network – This network includes input, output and 
hidden layers and the back-propagation learning algorithm is used for learning. 
• k-nearest neighbor (k-NN) - This method selects a group of K records from a training 
record set that has the closest records to the test record. Deciding the class of the test 
record according to the highest number of records in the selected neighborhood. 
• Genetic algorithm as optimizer – Since this algorithm works on its own rules, it can be 
used for irregular problems. It can rapidly scan a group of solutions and eliminate bad 
proposals and not affecting the final result.  
• Naive Bayes classifier - It’s estimated by the covariance matrix and it is a simple 
probability classifier based on the theory of Bayes. It needs only a small amount of 
training data to estimate the required classification parameters.  
• Deep learning technology – This method contains more image processing layers than 
the conventional image feature-based machine learning classifiers. Each layer is a typical 
neural network and uses the image itself as a single input.  
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2.6. PAST RESEARCH USING BPM IN HEALTHCARE  
By searching for the words BPM, BPMN, Healthcare, Oncology Screening and Process Modelling in the platforms Scopus and Google Scholar, the authors retain 
important information from 7 articles, presented in the following table (Table 2.2). To the best knowledge of the author, there isn’t yet a study about the 
implementation of BPM techniques in the process of Breast Cancer Screening.  




and case study 











• Any healthcare institution needs to have a detailed and itemized management of all 
processes present; 
• Business process Management is already a solution for process management in 
healthcare organizations with the purpose of improve work speed and efficiency, 
simplifying processes and reducing the use of resources; 
• Healthcare organizations have very complex structures, requiring adequate process 
management; 
• Healthcare organizations have problems in process management, namely: (1) 
Strategic level, (2) Tactical level and (3) Operational level;  
• In healthcare level BPM works in parallel with hospital information systems; 
• The services of a health institution are not independent from each other; they are 
interconnected and make the organization function as a whole; 
• To correctly apply BPMN, its necessary to understand the steps required to execute 
a given process and its surroundings, in order to represent the processes detached 
from their level of complexity;  
• BPMN will have an impact in increasing the level of quality of the services, in 
reducing costs and in identifying losses or wastes; 
• BPMN is intuitive, simplifying complex processes’ diagrams; 
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• Healthcare organizations are increasingly pressed to improve the quality of care 
services in an unfavorable context (increasing complexity in patient treatment and 
reduction of available resources); 
• Efforts to standardized and improve healthcare quality and efficiency have been 
done but it still persists a variation in performance; 
• Researchers and practitioners promote process redesign as a valuable way to reduce 
practice variation and improve the quality of care while considering efficiency issues; 
• According to BPM frameworks, the healthcare process lifecycle includes six phases: 
(1) definition, (2) specification, (3) analysis, (4) implementation, (5) execution and 
monitoring and (6) diagnosis and improvement; 
• Factors that limit the adoption of simulation-based analysis techniques in the 
healthcare domain: (1) healthcare processes are complex, distributed and multi-
disciplinary, (2) medical knowledge is often tacit and rapidly evolving, (3) the adoption 
of information technologies is still in its early stages and data when available is often 
disseminated in different information systems and (4) staff of healthcare 
organizations often lacks skills of modelling and analysis; 
• BPMN can satisfy the necessity of clinical pathway models for creating diagrams of 
these pathways and is able to manage the variability in a more effective way; 
• BPMN only works with functional characterization of processes without offering the 









Leung, W. and 
Nøhr, C. 
(Leung & Nøhr, 
2019) 
• Business process reengineering can be a method to find possibilities to improve the 
design of medical appointments systems, from “as-is” to “to-be”; 
• Since health care systems are composed by processes coordinated and logically 
sequenced, producing value to a client or costumer, they can benefit from using BPM 
approaches; 
• BPM gives importance on the use of information technology as a tool to improve 
business processes;  
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• BPMN supports technical users and business users to manage healthcare processes 
by providing a notation that both understands;  
• Devil's quadrangle can help healthcare industry to be conscious about problems in 
terms of time, quality, cost and flexibility as performance indicators; 
• Process redesign combines incremental improvement and extension of the existing 
process; 











• BPM has become to be considered a valuable asset in the healthcare domain;  
• BPMN designed to be understandable for business professionals and IT-specialists. 
Driving time-
dependent 




Combi, C.; Sala, 
P. and Zerbato, 
F. 
(Combi, Sala, & 
Zerbato, 2017) 
• Time management is important at all stages of business process design, enactment 
and analysis;  
• During process execution, different types of temporal conditions can limit how a 
process path is preferred; 
• Clinical domain it’s appropriate for business process modelling, considering its 
intrinsic organizational and decisional complexity; 
• BPMN constructs are enough to build process diagrams that succeed in specifying 
and enforcing temporal constraints; 
• BPMN process presents the main steps for the detection and treatment of Catheter-




















• Technologies of BPM, principally the design (modelling) aspect, are recognized to 
normally offer collaboration support by information technologies; 
• BPM is a valuable asset in the healthcare area because of the competitiveness, rapid 
advancement and the expansion of communication techniques and new technologies 
in all research domains, together with the effectiveness of BPM tools to automate and 
better manage business processes of organizations; 
• Technologies of BPM didn’t have a widespread adoption in the healthcare; 
• Process aware hospital information systems must be able to cope with exceptions, 
uncertainty and evolving processes; 
• Healthcare systems have particular modelling requirements: collaboration, 
















• Healthcare processes are complex and need transparency of all the process 
elements in order to achieve their implementation; 
• Healthcare process modelling as solution to reduce complexity and provide 
transparency; 
• Process modelling can define cooperative work, helping surpass the information gap 
between different actors; 
• Both clinical and organizational processes introduce dynamic activities, requiring 
adequate modelling methodologies; 
• Medical decision making, the clinical problem solving, is the foundation of clinical 
processes, being present in all stages of care (prevention, diagnosis, treatment and 
rehabilitation); 
• Graphical modelling languages offer a shared and understandable way to represent 
processes, simplifying context analysis and converting experiences into models;  
• Modelling healthcare processes is more complex than modelling other processes 
since medical processes are described by uncertainties, unpredictability, evolution, 
variability and difficult generalization;  
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• The modelled process should be predictable, repeatable, distributed, automatable 
and feasible; 
• BPMN is useful to describe the sequence of activities (normal flow of execution), the 
resources and the actors that are the executing units that can be related to the 
execution of the process; 
• BPMN graphs are often used to describe care pathways however, using these 
diagrams alone restricts the potential of process modelling on improving healthcare 
delivery. 




3.1. RESEARCH STRATEGY 
To achieve the goals of this dissertation the following steps were considered (Figure 3.1): 
1. Understanding the problematic of breast cancer screening; 
2. Identification of the current processes for the screening of breast cancer; 
3. Recognition of the Entities involved in the process; 
4. Design of the “AS-IS” diagram (modelling);  
5. Critical Analysis of the “AS-IS” diagram; 
6. Improvement proposal through the design of the “TO-BE” diagrams;  
7. Validation through interviews.  
 
 
Figure 3.1 – Methodology Scheme 
Through a literature review (chapter 2) the problematic of the breast cancer screening was presented, 
for fully understanding the process itself according to the state-of-the-art. To acquire this information, 
an online research through the platforms Scopus and Google Scholar was performed, which resulted 





















processes and all the entities involved, the nuclei of the south of the Portuguese League Against Cancer 
was used as case study and the information retrieved will be presented in the chapters 3.1.1 and 3.1.2, 
respectively. This enabled to modelling the current processes as “AS-IS” diagrams (chapter 4). In order 
to analyze the “AS-IS” diagrams and propose some improvements to the process, a reunion between 
the author, co-supervisors and the Regional Director of the Breast Cancer Screening from the LPCC was 
done. To support this, the four fundamental measurements (time, cost, capacity and quality) were 
used and the Lean methodology was followed (chapter 5). From here resulted the construction of the 
“TO-BE” diagrams for each process (chapter 6). This project ends with the validation through 
interviews to experts in the field (chapter 7). 
3.1.1. Identification of processes  
In this phase, the existing processes for the screening of breast cancer made by the LPCC were studied. 
To completely understand the processes and sub-processes, an interview to the Regional Director of 
the Breast Cancer Screening from the LPCC was required.  
These processes are documented in word or PowerPoint documents and was necessary to review the 
existing documents and record the undocumented processes in a more comprehensible, less complex 
and up-to-date language, using BPMN 2.0.  
The Table 3.1 has a concise explanation of the major processes identified within the breast cancer 
organized screening, which together form its macroprocess.  
Number and Name Type Description 
1. Health users’ invitation Process 
Asymptomatic people within an 
age range are invited to perform 
the breast cancer screening 
2. Screening Process 
Composed by the documents 
and exams required to screen 
the disease 
3. Reading of the exam 






Evaluation of the mammograms 
performed by radiologists 
4. Check-up consultation 
4.1. Sending Results 
Process 
Sub-process 
Consultation for health users 
with mammograms classified as 
R3, R4 or R5 to perform more 
exams 
5. Sending Results Process 
Sending the results to the family 
doctor 
Table 3.1 – Identified processes of the Breast Cancer Organized Screening 
3.1.2. Recognition of Entities  
Within a business process, there are several organizational entities that may interact with each other. 




The entities can be actors, systems or documents. The actors are the people that perform the activities 
in the process. The systems are the software used by the actors to perform their functions and to 
communicate with various stakeholders. The documents correspond to the methods used by the 
actors to share information between themselves, it can be digital or non-digital documents.  
In the Table 3.2 the actors are presented, as well as a brief description of their roles and the screening 
processes in which they are involved.  
Actor Description Processes where it arises 
Administrative 
Technician 
Person who gives administrative 
support for all the process. 
Present in all support units.  
1; 2; 3; 4; 5 
Radiologist Technician 




Person who is responsible for the 
reading of the exam and 
classification of it 
3; 5 
Doctor 




Person who will receive the letter 




Person who will be submitted to 
the screening process 
2; 4; 5 
Table 3.2 – Identified actors of the Breast Cancer Organized Screening 
In the Table 3.3 the systems are presented, together with a brief description of their role and the 
screening processes in which they are involved.  
System Description Processes where it arises 
SIRCM 
Informatic system that enables 




System used to send the 
invitation letters (both for 




System used to re-invite eligible 
women for screening which 
didn't attend on the first 




Database of health users’ 
information (family doctor, social 
security number, previous 
screenings) 
1 
Table 3.3 – Identified systems of the Breast Cancer Organized Screening 
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In the Table 3.4 all the documentation relevant for the processes already mapped, are identified, 
described and linked. The invitation letter and the anamnesis (both written in Portuguese) can be 
found in the annex I and II, respectively.  
Document Description Processes where it arises 
Invitation letter 
It is a printed letter sent to the 
women eligible for screening to 
invite her for the next screening 
in her residence area 




It is a digital document with the 
mammography exam 
2; 3; 4 
Letter with the result 
Letter sent to the family doctor 
with the result of the screening 
5 
Anamnesis 
Form filled by the health user 
with her personal information 
and answering some relevant 
questions for the screening 
2 
Table 3.4 – Identified documents of the Breast Cancer Organized Screening 
3.2. SELECTION OF THE SOFTWARE TO SUPPORT THE BUSINESS PROCESS MANAGEMENT  
Modelling helps to understand the business process and share this understanding with the people 
involved in it, while identifying and preventing issues (errors). In the market there are several 
software’s available to support business process management. In this work, Bizagi was the selected 
software to develop the diagrams. 
Bizagi provides leading process and workflow automation solutions to customers in industries 
worldwide. It supports the business process lifecycle through modelling, execution, management and 
continuous improvement, with minimum amount of programming (Nafie, 2016). Bizagi has 3 products: 
Bizagi Modeler, Bizagi studio and Bizagi Automation.  
Bizagi Modeler is a free of charge desktop application which uses BPMN as modelling notation and 
allow business experts to design, document and evolve their process models (Gjoni, 2015). High-quality 
documentation can be published in formats as Word, PDF, Web (HTML) and Wiki, and it’s feasible to 
import or export to interoperable formats such as Visio, XPDL or BPMN (Bizagi, 2019).  
While working with this software, it’s possible to create many diagrams and group them into models 
that can be stored as local files, .bpm file extension, or directly in the cloud (Bizagi, 2019). 
3.3. SELECTION OF THE TRANSFORMATION TECHNIQUE - LEAN 
In this project, the Lean approach was used as transformation technique since several studies 
evidenced that its principles and practices are being successfully used in healthcare processes 
(Amador, 2013; Shah, Sullivan, Gonyo, Wadhwa, & DuBois, 2013). It can be applied to improve staff 
productivity, standardize workflows and decrease patient waiting times while improving patient and 
staff satisfaction (Shah et al., 2013).  
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As mentioned before, the goal of this technique is the maximization of valued activities and 
minimization of waste. This waste can be classified as different categories (Shah et al., 2013; Teich & 
Faddoul, 2013):  
1. Motion – movement of patients or staff members that is unnecessary 
2. Transportation - movement of lab tests, supplies or equipment that is unnecessary 
3. Inventory – inappropriate amount of supplies available, both too much or too little 
4. Waiting – related to the time that the patient or staff waits until the next step in the 
process occurs 
5. Defects – errors or flaws in the process which can be related to poor labelling of tests, 
incomplete information in patients’ records and others 
6. Over processing – redundancies that can be observed in the process caused by unclear 
definition of what needs to be done and by whom 
7. Overproduction – excess work that doesn’t add value to the process. Producing 
something in excess, faster or earlier than required 
8. Under-utilizing staff – the under-use besides time-dependent it also involves deeper 
levels such as not sharing knowledge or not taking advantage of someone’s skills 
 
Teich and Faddoul (2013) suggest that lean implementation in healthcare should assign the patient to 




3.4. INTERVIEWS AS METHOD FOR QUALITATIVE VALIDATION  
After the development of the “TO-BE” diagrams a validation is required and in this way interviews one-
to-one were performed.  
This is a type of semi-structured qualitative interviews which uses a single respondent, being also called 
in-depth interviews. They are semi-structured because a pre-determined series of questions are asked 
but they enable an ongoing conversation, it’s an open-ended questioning (Bauer & Gaskell, 2000). This 
method explores the experiences of the participants and the value they give to them by encouraging 
the participants to talk about issues relevant to the research topic (Tong, Sainsbury, & Craig, 2007).  
There are other types of qualitative interviews as for example the use of focus groups. These method  
is similar to the type of interview chosen but instead of being individual interviews they are semi-
structured discussions composed by groups of 4 to 12 people (Tong et al., 2007). The choice of using 
individual interviews is due to the fact that it creates more detail, offers more insights into an 
interviewee’s personal thoughts, beliefs and point of views and it’s easier to schedule than the focus 




The macroprocess of the breast cancer screening were modelled as an “AS-IS” diagram, as well as all its sub-processes. Being presented in the following 
chapters.  
4.1. MACROPROCESS  
The macroprocess is presented in Figure 4.1 where several sub-processes can be seen. Each one of these sub-processes will be presented in the following 
chapters. In order to understand this macroprocess it’s important to know what are the meaning of the exam’s classifications: R1 - no abnormalities, R2 - 
benign findings, R3 - equivocal findings, R4 - suspected cancer and R5 - strongly suspected cancer.   
 
Figure 4.1 – Macroprocess for the Breast Cancer Organized Screening
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4.2. PROCESS “HEALTH USERS’ INVITATION” - AS-IS DIAGRAM 
The process “Health users’ invitation” (Figure 4.2) is performed by the administrative support unit which uses data provided by primary health care units 
(ACES). The health users’ database is sent as a Microsoft excel sheet and all that information is imported to the server SIRCM.  
 
Figure 4.2 – Process “Health users’ invitation” – AS-IS Diagram
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4.3. PROCESS “SCREENING” - AS-IS DIAGRAM 
The process “Screening" (Figure 4.3) is performed by an administrative technician and two radiologist technicians to an eligible woman which is called as 
health user. In this process there is one important document - the anamnesis - that must be filled out by the health user every time that is screened. 
 
Figure 4.3 – Process “Screening” – AS-IS Diagram 
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4.4. PROCESS “READING OF THE EXAM” - AS-IS DIAGRAM 
The process “Reading of the exam” (Figure 4.4) is performed by the radiologists but relies on the help of the reading, administrative and check-up support 
units. The consensus conference is done by the five radiologists of the organization. The sub-processes “Check-up consultation” and “Sending results” will be 
presented in the next two chapters.  
 
Figure 4.4 – Process “Reading of the exam” – AS-IS Diagram 
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4.5. PROCESS “CHECK-UP CONSULTATION” - AS-IS DIAGRAM 
The process “Check-up consultation” (Figure 4.5) is performed by the check-up support unit and the doctors to the health user. 
 
Figure 4.5 – Process “Check-up Consultation” – AS-IS Diagram
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4.6. PROCESS “SENDING RESULTS” - AS-IS DIAGRAM 
In the process “Sending Results” (Figure 4.6) the radiologists, the administrative support unit and the family doctor will be involved in delivering the result to 
the health user. The results are delivered by the family doctor due to privacy issues. 
 
Figure 4.6 – Process “Sending Results” – AS-IS Diagram
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5. CRITICAL ANALYSIS 
Before updating a process is required a shared understanding of the current state of the process and 
finding the level of agreement with the stated organization’s objectives. This is achieved by process 
analysis (ABPMP, 2013).  
The Breast Cancer Organized Screening under study follows the macro recommendations of the 
European Commission, being well stablished the processes involved. However, healthcare 
organizations may decide on the revision of operational processes in order to best fill the goals defined 
and revised periodically at the European level. 
Through the reunion performed between the author, co-supervisors and the Regional Director of the 
Breast Cancer Screening from the LPCC, and after the presentation of the “AS-IS” diagrams of the main 
processes, it was observed that some of the problems in the breast cancer organized screening were: 
(1) the participation of the health users; (2) the time the process takes; (3) the availability of the health 
users’ information (from the available contact to filling out the anamnesis form). 
After the identification of these problems, a brainstorming session was performed to propose some 
improvements. To complement this session, an online research was done focusing on strategies to 
improve the participation rate in the screenings.  
The Table 5.1 presents the critical analysis to the major processes identified and some of the 
improvements that can be done.  
Process 
name 
Critical Analysis Improvement proposals 
Health users’ 
invitation 
1. After receiving the health 
users’ information and before 
its importation to the SIRCM, 
it’s required a manual pre-
treatment where the terms 
are converted into the term 
accepted by the system. As for 
example, the system only 
accepts the name “Maria” as 
“M.” so for each woman 
called Maria this conversion 
needs to be made what is a 
time-consuming process. 
1. To change the manual conversion 
of the terms into an automatic 
process a data cleaning before the 
importation to the SIRCM would 
be done. 
2. An invitation letter is sent 15 
days earlier to the health user 
but no telephone contact is 
done before the screening. 
The health user is only 
contacted by telephone if she 
didn’t appear in the day of the 
screening. 
2. According to the contact that is 
available, the health user would be 
contacted every time through the 
same way. This means that: 
a. If the address it’s the only 
available contact, the 
health user would always 




b. If the health user had a 
telephone number or an 
email address as contact 
way, this would be the 
method used. This would 
enable that a reminder 
message (through SMS or 
email, respectively) was 
sent in the day before the 
screening appointment. 
3. With the invitation letter goes 
information about the 
process itself and clarification 
of doubts that may exist. 
3. When contacting the health user, 
along with the information that is 
already provided it would also be 
asked them to complete the 
anamnesis online form before the 
screening day. 
 
4. The invitation letter is signed 
by the Regional Director of 
the Breast Cancer Screening. 
4. The reminder letter could also be 
signed by the Regional Director of 
the Breast Cancer Screening and by 
the health user’s general 
practitioner in a way to improve 
participation in this program. 
Screening 
1. Anamnesis is a form filled in 
the day of the screening and is 
required in the process 
“Reading of the exams” where 
the radiologist will combine it 
with the mammograms and 
previous information. 
1. The form could be filled previously 
to the day of the screening, online, 
through the creation of a site and 
an app. Which would reduce the 
time of the screening itself.  
2. The participation in the 
screening varies according to 
location and other variables. 
Health users that were 
recently examined through an 
opportunistic screening don’t 
show up at the organized 
screening however they count 
as absences, decreasing the 
participation percentage.   
2. To improve participation in the 
screening a reward system (like 
body creams, soaps, hygiene 
products or others) could be 
established through the 
development of agreements with 
renowned brands. In order to 
exclude the health users that 
didn’t went to the screening 
because they were already 
screened, from the participation 
percentage, the anamnesis form 
could have a field related to this 
question.  
3. The exam performed is the 
mammography which is the 
golden standard but has some 
disadvantages. 




1. The evaluation of the 
mammograms is done by a 
double-blind reading by two 
1. Through an artificial intelligence 
(AI) system a sorting in the exams 
could be done. This would create 
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radiologists but there is no 
order of priority within the 
exams, which can lead to an 
increase in the response time 
to the most severe cases. 
two different paths according to 
the classification obtained here. 
Every exam would be seen and 
evaluated by the two radiologists 
but this would create a priority 
order. If the exam, in the AI, gets a 
classification of R1 or R2, it would 
stay in the queue. The exams 
classified as R3, R4 or R5 would get 
a priority and would be observed 
first. After these exams have been 
observed the R1 and R2 exams 
would get in the flow again and 
would be evaluated. 
Check-up 
Consultation 
1. This is a stressful process that 
brings concern to the woman 
and that can require special 
accompaniment. 
1. The creation of an optional 
consultation with a psychologist, 
on the day of the check-up 
consultation would help reduce 
the stress associated with the 
process and provide a better 
accompaniment to the woman. 
Sending 
Results 
1. The results are sent to the 
family doctor approximately 
15 days after the screening 
but the health user is not 
notified about the availability 
of the results. 
1. Through the creation of an app a 
notification could be sent to the 
health user informing about the 
availability of the results of the 
exam, in the health care center 
with her family doctor. 
Table 5.1 – Critical Analysis and improvement proposals for the identified processes. 
Besides the impact that the creation of an app would have in the process “Screening” as presented 
before, it could also have a positive impact in the breast cancer organized screening as a whole. 
Because this app could have much more features like, every two years remind the woman that the 
following screening is almost there; or the woman could upload her previous results to the app so she 
can have a full picture about her health or even get some information about all the process (frequently 
asked questions, notices about the topic, tips to deal with the associated stress).  
To reach the improvement proposals present in the previous table, was followed the principle of the 
Lean methodology, elimination of the waste or non-value-added work, and complemented with the 
four fundamental measurements (Time, cost, capacity and quality). In terms of the lean technique this 
improvement proposals are related to the elimination of different wasteful procedures that could be 
classified as waiting and defects waste. 
− In the “Health users’ invitation” process, using data cleaning to treat the data, the time 
of the process will be reduced. With the use of the appropriate type of contact, which 
reduce the letters sent, the cost of the process will also be reduced.  
− In the “Screening” process, with the use of an online form for the anamnesis, there will 
be a reduction in the time of the process because the health user will only need to go to 
the mobile unit and perform the mammography exam and this possibly would increase 
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the number of women attended in the same day because it would need less time per 
women, increasing the process capacity.  With this, we can observe a reduction of the 
waiting waste. With the reward system, if more women go to the screening the capacity 
of the process would also increase. 
− In the “Reading of the exam” process, by using the AI to sort the mammograms the 
response time would decrease in the most severe cases, and the quality of the 
evaluation would increase because it would be checked by radiologists and informatic 
systems. Through this measure it is possible to eliminate defects waste because it is 
expected a reduction in the errors of the evaluation.   
− In the “Check-up consultation” process, the incorporation of the psychologist 
consultation would increase the quality of the process as a whole because it would bring 
more support and accompaniment to the women, decreasing the stress associated. 
With the health user at the center of this analysis, this measure would improve their 
comfort, which is one of the suggested key performance measures to correctly 
implement lean.  
− In the “Sending Results” process, the notification of the availability of the results to the 




6. TO-BE MODELS 
In the following sub-chapters, it will be presented the “TO-BE” diagrams for each process identified.  
6.1. PROCESS “HEALTH USERS’ INVITATION” – TO-BE DIAGRAM  
With the redesigning of the “Health users’ invitation” process resulted a diagram with more steps however, it is more efficient in time and cost. It is possible 
to observe that the administrative support unit will follow three different pathways according to the contact form available for each health user (Figure 6.1).   
 
Figure 6.1 – Process “Health users’ invitation” – TO-BE Diagram 
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6.2. PROCESS “SCREENING” - TO-BE DIAGRAM 
In the “TO-BE” diagram for the process “Screening” (Figure 6.2) the administrative technician needs to confirm that the anamnesis was filled online by the 
health user. If it was already filled out, the health user would go directly to the exam appointment otherwise needs to fill it online before goes to the exam 
appointment. To be possible to assure that every health user could fill their information online a computer should be available in the mobile unit and 
administrative support would be offered.  
 
Figure 6.2 – Process “Screening” – TO-BE Diagram 
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6.3. PROCESS “READING OF THE EXAM” - TO-BE DIAGRAM 
For this process the “TO-BE” diagram (Figure 6.3) brings two pathways according to the classification obtain in the artificial intelligence technique used. This 
technique could be, for example, the convolutional neural networks (CNN) because it has been referred by recent studies that it can be successful in several 
tasks in the healthcare sector namely in multiple applications in radiology (Geras, Mann, & Moy, 2019). Additionally, it has presented good results for image 
recognition problems (Ibrahim et al., 2020). These pathways would make a faster track for the most severe cases (R3, R4 and R5) and a slower one for the 
ones that didn’t demonstrate malignancy (R1 and R2).  
 
Figure 6.3 – Process “Reading of the exam” – TO-BE Diagram 
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6.4. PROCESS “CHECK-UP CONSULTATION” - TO-BE DIAGRAM 
The “TO-BE” diagram for the “Check-up Consultation” process (Figure 6.4) brings one more step compared with the “AS-IS” diagram however it doesn’t add 
unnecessary time since it would be an optional step for the health user, with their well-being in the center of this proposal.   
 
Figure 6.4 – Process “Check-up Consultation” – TO-BE Diagram
43 
 
6.5. PROCESS “SENDING RESULTS” - TO-BE DIAGRAM 
In the process “Sending Results” as in the previous process, the “TO-BE” diagram (Figure 6.5) carries one more step but it is a step related with the use of the 
app which doesn’t bring any additional time to the process.  
 




To validate the “TO-BE” diagrams, which included the proposed changes, four interviews were 
conducted with experts. These interviews included two members of the LPCC, the Dr. Fernando Lage, 
radiologist and technical director in the nuclei of the south of the LPCC, and Natércia Almeida, 
administrative technician of the check-up support unit of the LPCC. It also included a health user, Rita 
Teles Branco, who have participated four times in the organized screening performed by the nuclei of 
the south of the LPCC and Dr. Henrique Nabais, gynecologist and director of the gynecologist unit of 
the Champalimaud Foundation.  
These experts were chosen due to their high expertise in breast cancer organized screening. Dr. 
Fernando and Natércia represents two different types of employees of the LPCC, bringing their explicit 
and tacit knowledge of the process; Rita represents the health users, the central actors of the process; 
and Dr. Henrique represents the doctors that follows the health users externally to the organized 
screening studied, bringing his experience in the area from his professional background.  
These interviews were done separately and by the author through an online platform. Each interview 
started with an explanation of the main objective of the dissertation and the presentation of the “AS-
IS” and “TO-BE” diagrams for each process identified.  After this, four questions were made to the 
participants for them to answer according to their expertise, knowledge in public health and believes.  
The four questions made were:  
Q1. Do you agree with the proposed changes presented in the “TO-BE” diagrams? If not, which of 
the changes do you disagree with? 
Q2. Do you believe that the proposed changes are sustainable/feasible? If not, which one of them 
do you consider unsustainable/unfeasible? 
Q3. Do you have any suggestions for changes? 
Q4. Would you support the implementation of these changes? 
The interviews were recorded, transcribed and translated and a synthesis of the answers will be 
presented below.  
Regarding Q1, the answers were:  
Interviewee 1 (I1): I think that the psychologist should be earlier in the process. There was a time that 
we had a psychologist in the check-up consultation to give support to the health users but we 
concluded that the local support in the check-up was too late. I think it should be in the health centers. 
When the health users receive the information that they will need to go to the check-up consultation 
they get in panic. It’s in that moment that the psychologist is important, not after, when they are 
already in front of the radiologists and they explain them what’s going on, there they normally get 
calmer. The aspect of a previous support in the health center was sometimes important.  
As for the more computerized part, it’s for sure convenient to do it, whatever is possible to digitalize 
or computerized becomes more practical. However, there are some difficulties according to the 
respective health user. There are several people with more than 60 years that don’t have any 
45 
 
informatic capacity or not even know how to write. Which would be a problem but would be solved 
locally with the help of the administrative technicians. In my view, that support of the administrative 
for the fill of the questionnaire would be important. Not necessarily the availability of the computer 
for the health user but the support of the administrative to fill it.  
Sending an email to the health user becomes difficult because most of them don’t have it.  
The usage of artificial intelligence techniques is welcome but I think it won’t be anytime soon.  
Interviewee 2 (I2): I don’t agree with the use of a data cleaning program, I think the excel does it and 
if someone program the excel for us to do it, it would be enough.  
About the usage of the email, in Setubal and Lisbon yes but in some areas, where the network is weak 
it would not be possible. And in some places, such as the Alentejo where there is an elderly population 
with low education level and where sometimes they don’t even know how to write it would not be 
possible. Although the age range for the screening is between 50 to 69 years old this question is still a 
reality. Another question that concerns me is if the invitation can be done through the email according 
to the general regulation on data protection (RGPD) rules. The message through the phone I think it’s 
good because sometimes people don’t answer the phone when I call them and after I send them a 
message they already answer.  
The reminder message is interesting. A nice message/reminder in the day before of the screening is 
extremely interesting in the times we live. We live always running and with so much to manage and 
would be interesting.  
The reminder message being signed by the family doctor is interesting but there is a question, some 
health users don’t have family doctor so I would recommend that it was signed by the director of the 
health centers where they belong.   
I agree with the arrangements with renowned brands. Very enjoyable and could be suitable with the 
place where the person lives as for example in Campo Maior could be offered a box with coffee. But 
useful things.  
The artificial intelligence would benefit the health user. I think it’s something to consider, it could value 
some issues that are not valued but it could also exacerbate in situations that automatically they see 
that are benign, such as calcifications. But I wonder whether the number of consensus meetings would 
increase.  
The appointment with the psychologist, we used to have it in the past and honestly, I’m not sure if it 
would be better before or after. I have cases of people who tell me that they haven't slept in a week 
since they received our phone call and I know people who leave devastated from there. When we call 
to say that there is something that needs to be better evaluated, there are people who react to say 
that they have nothing, others to say that they are going to die and others that think that everything 
is fine. What I want to say is, imagine that I say “Then, if you want, you can have a consultation with a 
psychologist”, what can this imply? That the health user questions that there is something serious after 
all, worse than she thought. If it is R3 we tell her that it is just doubts, if it is an R4 or R5 we already say 
that in fact there are changes that need to be revised. And this already makes them think that 
something is wrong, if I am going to talk about a consultation with a psychologist, they will think more 
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that something is wrong. I find it interesting because if you are nervous is good to be able to talk to 
the psychologist. Maybe talk about that chance only in the day of the check-up consultation.  
The app would be interesting. Beneficial to the health user.  
Interviewee 3 (I3): At a first sight there is nothing that I disagree with. There are things here that can 
be really good. Concerning the letter being signed by the family doctor, I think that the LPCC is already 
a very credible entity but if the reminder message it’s complemented with the signature of the family 
doctor, it could reinforce the participation in the screenings, mostly in smaller communities where the 
family doctor has an increased weight because it’s the doctor that we know better and we always turn 
to. However, I think that where it would be important that the family doctor was involved is in the 
invitation to the check-up consultation because the first time that the health user do the screening she 
doesn’t know how the process is done and for example what does the classification R1 to R5 mean. I 
think it’s important that from then on, the family doctor accompanies the process. The result must go 
to the family doctor and then the family doctor must accompany the health user.  
Sending the remembering letter is something that I think that can be very important because I have 
the feeling, not only as a health user, that there are things that we forgot because of the speed that 
life takes nowadays and the number of things that we accumulate. I perceive in my community, which 
is a small community, that a considerable number of people do not go to the screening because they 
forget. They receive the letter some time before but doesn’t remember anymore. In this way having a 
reminder is fantastic, great.  
I think that the possibility of the R3 to R5 cases being analyzed first could be good, avoiding that the 
most severe cases being delayed. However, I think that I’m a little bit sceptic about these technics. I 
fear that there is any factor that could not be thought which transform a R3 into an R1, I don’t know.  
The psychology consultation, I confess that I don’t know if it’s too premature in the process. I think it’s 
good it’s existence but maybe not in the beginning of all of this. Let me tell you that I’m an oncology 
disease survivor, not from breast cancer, but I also have familiars that had breast cancer so I’m 
additionally a companion and I think that in this first phase we do the mammography, we get scared, 
but we have no time or desire to open the door for the psychologist. I think that this support is very 
important in the middle of the process, in the beginning or at the middle of the treatment. There yes, 
I think that knowing that this tool exists is good and helpful. But this soon I think no one will want it. 
The majority resorts to it when the cancer has returned.  
The app I think is fantastic for those who are informed, but today a large part of the health users is still 
informatically excluded.  It’s good to have both options (fill the anamnesis online at home or locally). 
The health user who already has everything filled in goes immediately to the exam, otherwise, it’s like 
today, it’s filled in locally with the help of the administrative. Between screenings, there are situations 
that change, such as the question “do you have cases of breast cancer in your family?”. The first time 
that I did the screening only my mother had it but the second time I did the screening my sister also 
had it. This update must always be done.    
Interviewee 4 (I4): I think that these changes are very interesting. We need to think that the women 
that are screened are dynamic. What I mean is that the women that today are 50 years old, tomorrow 
are 60 years old, but the women that today are 30 years old, ten years from now are 40 and then 50 
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years old and will be screened, so I don’t have any doubt that it should be mandatory to introduce 
here some facilities from the point of view of the computerization of this. So, the applications are 
essential because at a certain time it gets in the routine. If in a 60-year-old woman today, in the vast 
majority of them, it is not routine to use an application in all women aged 30, it is already part of the 
routine. Thus, we are preparing the way. Maybe this will not happen in the next year but we are 
preparing the way for five or ten years from now. This must happen. Therefore, I think it’s good.  
Adapting the contact medium to the health user's preference is generally more convincing. If you make 
a phone call inviting a woman to be screened it is usually easier to convince the person to go for 
screening or if it is by email, if that is the woman's preferred mean, it is usually easier if it is the way 
the woman prefers more. On the other hand, it is also certain that the woman received the invitation. 
In terms of the psychologist I think it is fantastic. That option is the best, having the door open to the 
psychologist support.  
The point “sending results” having an application that contains the report or at least something that 
says what was the result of the screening I think it would be interesting.  
Considering Q2, the answers were:  
I1: I think they are feasible but it’s necessary that the administrative technicians of the screening have 
enough informatic training to align with the filling of the anamnesis to not appear with wrong 
information.  
Concerning the execution of the reading of the exams, they are already done with a considerable 
speed, sometimes there are some delays but most of the times they are done 4 or 5 days after the 
mammography exam being performed. Nevertheless, a sustenance of the artificial intelligence not 
only would enable the selection of the cases and put them first in line to go to the reading and check-
up consultation, but would also help us to not make errors because everything that calls our attention 
to any pathology that may pass without us notice it is good. Because sometimes these readings are 
300 or 400 cases per session and gets a point where a person can fail and miss something. So, artificial 
intelligence is welcome.  
I2: Data cleaning I’m not sure if it’s viable in terms of cost but the rest I think that there is nothing I 
consider that would not be feasible. Artificial intelligence brings costs but I think that we would benefit 
from it. Everything that serves to improve participation of the health users I agree.  
I3: I not only think they are feasible as I also think it’s the way. And the proof of this is the current 
situation (Covid-19), which changed the world, the teleworking, tele-school and tele-consultations 
have started. I think that the digital and computerized part of everything is growing and we can’t run 
from it. And we need to reinvent ourselves. I think it’s feasible and recommended to do it. In rural 
areas, where there is an elderly population, having a phone to make calls is lucky. So, I think that it’s 
important to always have a complement.  
I4: The only question that it seems to me that would be a little bit more difficult is the availability of 
the psychologist. Because to have a psychologist is required an adequate space. It’s something to think 
about. Not only to have a psychologist always available but also having a place that offers some privacy. 
But yes, I think that doing this consultation in the check-up consultation would be useful. Because in 
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the screening itself, whether we want to or not, most women don’t go very anxious, they’re anxious 
while doing the exam but it’s in that moment, after she becomes calm. When she goes to the check-
up consultation she already knows that something is not exactly how it was supposed to be. Therefore, 
I think that the invitation to the check-up causes anxiety to the women and in that way the psychologist 
consultation is appropriate in the moment of the check-up.  
About Q3, the answers were:  
I1: Regarding the process as currently is, the suggestions would be mostly technical improvement, 
essentially at the level of the mammography technique. Which means improving in the quality of the 
mammography of diagnosis and introduce the tomosynthesis because it’s an advantage to correctly 
assess injuries and detect multicentricity and multifocality more easily than what is currently done.  
Another aspect is having access to the entire panel of the hospitals in order to have feedback on what 
happens later with the users we refer to the hospitals to be treated. It is something that has not 
happened, many hospitals do not send the results. 
I2: I would suggest not to only ask if the person wants to go to the psychologist consultation in the 
moment of the invitation to the check-up consultation. It could be talked about that possibility in the 
day of the screening and if the person needs to go to the check-up consultation she would already 
know that she had the right to it and that it is not because of the severity of its lesion. 
What could be interesting in the app proposal is having a tablet in the entrance of the screening mobile 
unit where the health user could fill out her information’s and when she got into the unit the 
administrative technician would confirm if it is filled or not. If it is already filled the administrative 
technician would only review the information with the health user otherwise she would help the health 
user to fill it. However, reducing the time of the administrative work would create stress to the 
technician team.  
Another suggestion would be that the app was related with the reward system, like if the person install 
the app she would receive the gift. And that the app had a feedback system. Every step that the health 
user passes in the screening she would receive a message, smile or like. But in some automatic way 
that doesn’t need that the professionals were always pressing a button.  
I3: The suggestions that I have are that the family doctor call the health user to invite her to the check-
up consultation and accompanied her since then. And that the psychologist consultation be later in 
the process. I think it’s a waste do it in the proposed step. 
I4: The suggestions that I have is related to the availability of the images of the exams through the app. 
Here I would discuss something with the radiologist that maybe it’s not possible, I don't know, I don't 
know if, from an ethical point of view, it is acceptable but to have an application in which the images 
from the mammography exams were available. Why do I say this? Because nowadays the screening of 
the LPCC ranges from 50 to 69 years old. It’s clear that with the increase in the average life expectancy 
of women (around 84 years old) many women undergo mammography after 69 years old and often do 
not have access to the images of previous exams. What would be important so that there is a possibility 
of comparison in the future. Because nowadays, despite the population-based screening that we owe 
to the LPCC, which is free and sometimes we don't even realize the enormous quality of this screening 
in Portugal, is excellent. However, what is certain is that it ends at 69 years old, it must end at some 
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age, but what is certain is that sometimes there is a woman aged 71/72 years old who are women who 
are very well with an excellent general condition and who continues to be screened because after all 
if a carcinoma is diagnosed it will be treated. Individually, obviously but in that way having the last 
images available at the end of the screening would be good. The availability of these images can also 
be an added value because the user may have the so-called interval cancer, the woman is screened 
every two years and after one year the woman may have a breast lump and needs to do an interval 
mammography that will not be done within the screening so if you have the images available it makes 
it easier. 
Another suggestion would be using a tablet in the mobile unit to fill the anamnesis instead of a 
computer.  
What we could done more is for example complement the application with more health features, like 
for example the national vaccination plan. An app that combines both primary and secondary 
prevention because it’s with these types of prevention that we can reduce the mortality of severe 
diseases such as cancers, infections and others.  
Concerning the last question, Q4, the answers were:  
I1: I would support the implementation of the proposals that I mentioned that I agree with. 
I2: Yes, I would support the implementation. I’m not sure about the costs but whatever is to improve 
I think it is good. 
I3: Yes, I would support. I think it’s the way. We need to rethink several things. 
I4: Of course, yes. Whatever it is to innovate, innovate in this way. Especially because this innovation 
is interesting because it does not create a rupture. Of course, sometimes disruptions are interesting 
and important to happen. In this system that we currently have for screening, which works pretty well, 
what we want is to improve it. We already have a base structure that works relatively well, but we 
want to improve it. What is happening does not need a break, it just needs these changes and to think 
about the process and get better. I think it's very good, something that was thought out and that looks 
interesting. I think it can make everything a little easier, more economical, except the psychologist. 
That was interesting. I was thinking about volunteering but I'm afraid in this respect, do you know why? 
Because it is not just any psychologist who can support you at this stage, you must have some 
experience in the area because if not it will spoil more than help. The way to deal with this anxiety 




8.  DISCUSSION 
In this section, it will be made an analysis of the improvements suggested, according to the answers 
obtained through the interviews performed in the validation phase and complemented with previous 
studies.  
The validation phase focused on understanding the viability of the improvements suggested, their 
utility and the support that these changes in the process would have in the main actors and in public 
health in general.  
Most of the proposed changes were accepted by the four interviewees, however some of them 
brought some questions, such as the proposal of the psychologist consultation. In this case, all the 
experts mentioned it as a good improvement, but the moment where it should happen was debatable. 
Being the purpose of this consultation to help and support the health users, the opinion of the health 
users should be considered and the interviewed one thinks that this consultation should only exist 
later in the process. Suggesting that it should happen only in the treatment because she fears that in 
the process of the screening the health users won’t have the time or predisposition to open the door 
of the psychology support. However, according to Pineault (2007), it has been recorded 
demonstrations of anxiety at every steps of the screening, from the phase where the women receives 
the letter with the invitation to participate in the program to the waiting period, where they experience 
uncertainty feelings. It has been referred that offering social support by healthcare professionals 
reduces health users’ anxiety, contributing to well-being by satisfying the person’s needs for assistance 
and information (Pineault, 2007). When offered in an early stage, it helps preventing increased anxiety 
during later stages (Pineault, 2007). Knowing this, offering psychological support early in the organized 
screening program seems to facilitate the whole process. 
The usage of the reminder message was considered a good asset by the interviewees, being this finding 
aligned with previous research such as those developed by Camilloni et al. (2013) and Duffy et al. 
(2017). As maximizing women participation is a goal of every screening program and impacts on its 
cost-effectiveness assessment, several studies have focused this issue. In this way, although the 
changes proposed in this dissertation were not implemented yet, some of them are already supported 
by other studies as is the case of this reminder calls which are considered as a way to improve breast 
cancer screening uptake and participation (Camilloni et al., 2013; Duffy, Myles, Maroni, & Mohammad, 
2017). 
It was mentioned that the participation of the family doctor in the invitation to the screening could 
reinforce the participation if it was in the reminder message. In some studies, was evidenced that the 
signature of the health user’s general practitioner in the invitation letter is a good method to improve 
the participation in these programs (Camilloni et al., 2013; Duffy et al., 2017), what corroborates this 
idea. It was also suggested that instead of being signed by the family doctor, it could be signed by the 
director of the health center where the health user belongs, because some of them don’t have a family 
doctor.  
The interviewees evidenced a possible negative impact of many computerized proposals in health 
users, such as the introduction of an app or the use of email. This concern is because nowadays most 
of the health users covered by the screening still don’t use applications routinely, and some of them 
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not even use the phone. But all the experts agreed on implementing these changes, while maintaining 
the traditional options for the health users with lower levels of digital literacy.  
The artificial intelligence causes some doubts about the costs and if it’s a closer possibility or not. But 
the experts mentioned that it would help and improve the process. Additionally, it was suggested that 
more than accelerate the process, AI could call the attention of the radiologists to lesions that could 
pass unnoticed, due to the number of exams to analyze in only one session. Some studies stated that, 
although the AI algorithm had performed worse than the highest-performing radiologists, the usage 
of this techniques might have an impact in the associated workload of the screening and even on the 
quality of the screening program (Sechopoulos & Mann, 2020). Also, it has been demonstrated that 
breast radiologists have higher diagnostic performances with support from AI systems compared with 
reading unaided (Rodríguez-Ruiz et al., 2019), confirming the experts’ beliefs. In agreement with what 
was mentioned by the experts interviewed, Rodríguez-Ruiz et al. (2019) stated that AI systems has the 
potential to make radiologists’ readings more efficient by improving the evaluation of equivocal cases 
and increasing their attention in the most suspicious examinations while reassuring them in faster 
readings of the least suspicious examinations. From the point of view of cost-effectiveness and 
considering the increased workload of the screening programs, the performance benefit of using AI 
support is additional higher by the fact that radiologists do not extend the reading time when using 
this system (Rodríguez-Ruiz et al., 2019). Previous studies refer that AI will have, in the near future, an 
important role in the evaluation of mammography exams, especially in the screening setting (Geras et 
al., 2019). All these evidences demonstrate the importance and relevance of the AI techniques in that 
field, supporting this suggestion and its implementation in the breast cancer organized screening 
program studied.   
Concerning the viability of the changes suggested in this dissertation, everyone thought that they were 
feasible but that some need to be carefully implemented. The psychologist was indicated as possibly 
the most difficult to implement due to the availability of the psychologist, the required space and the 
experience that the professional needs to have.  
Regarding the suggestions of the interviewees they were mostly related with the use of the app, having 
been suggested the usage of a tablet in the entrance of the mobile unit, instead of displaying a 
computer to fill the anamnesis form, and that this app could be complemented with other features. 
Another recommendation is the time that the psychologist consultation should be presented as an 
option and the step where it should be placed, which changed between the interviewees. Other 
suggestions were related with the mammography exam: (1) last mammography exam, within the 
breast cancer organized screening, available for example in the app, as a complement to future exams 
outside the organized screening; (2) tomosynthesis as complement to the mammography exam itself, 
to improve the detection of the lesions. This comes in agreement with what was mentioned before, in 
chapter 2.2.2, that the use of digital breast tomosynthesis as routine for screening programs is being 
discussed, however until now it’s not routinely used in any screening program (IARC, 2016).   
To conclude the validation phase, it was asked to all the interviewees if they would support the 
implementation of these proposals, to what all of them demonstrated support, confirming the 




In this work, was performed an analysis of the process of the breast cancer organized screening 
followed by the nuclei of the south of the LPCC and the research objectives, previously proposed, were 
achieved.   
This study started with a research in three major subjects - breast cancer, oncology screenings and 
business process management - bringing support to the analysis of the breast cancer organized 
screening and the development of its respective “AS-IS” and “TO-BE” diagrams. These diagrams were 
later analyzed and validated through interviews with four experts. 
This dissertation was developed with the purpose of improving the process of the detection of breast 
cancer, which is a disease with high incidence and mortality. The focus of this work was the breast 
cancer organized screening instead of the opportunistic one, considering its importance and features 
that the latter doesn’t demonstrate.  
Both research questions were answered through an investigation in the field complemented with the 
available literature. RQ1: Which are the processes involved in the breast cancer screening in Portugal? 
This question was answered with the development of the “As-Is” diagrams, which correspond to the 
five principal processes of the breast cancer organized screening (1 - Health users’ invitation; 2 – 
Screening; 3 - Reading of the exam; 4 - Check-up consultation; 5 - Sending Results). The identification 
of these processes resulted from reunions with the LPCC, where the flowcharts of the process and its 
main documents were presented. Through the process of answering this question all the steps and 
actors involved were described to correctly define each process.  
What brings us to the second research question. RQ2: What are the constraints of the breast cancer 
screening programs? The answer to this question also resulted from the meetings previously 
mentioned but, to properly answer it, a deep investigation in what happens in other breast cancer 
screening programs, both in Portugal and in the world, was required. The main constraints identified 
are the participation rate in this type of programs (poor information about the topic and anxiety felt 
in the process are some of the reasons for the health users to don’t participate), the time the process 
takes and its efficiency (considering the treatment of the health users’ data and the process for the 
mammography evaluation).  
The program developed by the LPCC is a well stablished process which already proved its value, 
nevertheless there is a place for improvements. Through this study, and the development of the “AS-
IS” diagrams, it was possible to detect some points that could be changed to reduce the time of the 
process, the effectiveness of it, or even to improve the comfort of the health user. The presentation 
of the “TO-BE” diagrams in the validation interviews mapped the value of these suggestions.  
In summary, process modelling was important to clearly understand the mainly actors of breast cancer 
screening and review the entire process in order to correctly identify the breaking points and struggles 
within it.  
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9.1. LIMITATIONS  
There are three main limitations of this study that should be considered. First, the validation group for 
the new diagrams was composed by a small number of experts. However, in a way to reduce this 
constraint it was performed individual interviews which offers more insights into an interviewee’s 
personal thoughts, beliefs and point of views and the people interviewed were selected due to their 
expertise and relation to the theme, impacting in different areas of the process. This gives us a 
complete overview of the impact of the proposals in the whole process. 
The second limitation identified is that as best as the proposals may seem, only after its 
implementation and an experience period, it would be possible to completely understand its feasibility 
and impact in the process itself, and as ultimately its impact in the screening of the breast cancer. 
Nevertheless, this could not be done in the scope of this master’s thesis due to the short period 
available and may be addressed by future empirical research.  
Finally, it is not possible to incorporate the change of the mammography exam to another exam since 
it’s a decision with legal impacts, which needs to be supported by additional research. Thus, despite 
existing studies in the field, it was not possible to incorporate it in the “TO-BE” diagrams of this 
dissertation.  
9.2. RECOMMENDATIONS FOR FUTURE WORKS 
As future work we suggest that the diagrams should be evaluated by a bigger group, and possibly 
through a focus group meeting. This would promote discussion about the proposal improvements, it’s 
strengthens and weaknesses, but it would also stimulate the proposal of new ideas and the discover 
of other hidden problems.  Also, to completely understand the usability that the psychologist 
consultation would have for the health users, and in which step it should exist, more health users 
should be interviewed.  
Secondly, as previously mentioned, and due to the lack of time associated with this master’s thesis, 
the implementation of the new diagrams proposed was not possible. In this way, as future work we 
suggest to try to implement these new processes and evaluate its impact in the process and in the 
detection of the breast cancer.  
There is one idea mentioned by Bobridge et al. (2017), which was not applied in this research, also due 
to time constraints and complexity, nevertheless it could be a way to improve the participation in the 
breast cancer organized screening, while improving the participation in other oncology organized 
screening programs. This consists in the use of a “one stop” screening shop, which means that different 
types of oncology screenings would be delivered at the same time and location (Bobridge, Price, Gill, 
& Taylor, 2017). In this way, we suggest as future work the use of a questionnaire to understand the 
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